vimarsana.com

Latest Breaking News On - Obstructive hypertrophic - Page 1 : vimarsana.com

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics-incorporated
Primary-results
Positive-topline-results
Obstructive-hypertrophic
Additional-analyses
Exercise-capacity
Late-breaking

Cytokinetics Announces Four Upcoming Presentations at the

SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the.

Oregon
United-states
Sara-saberi
Diane-weiser
Morrism-kim
Nosheen-reza
Oregon-health-science-university
University-of-pennsylvania
University-of-michigan-health-frankel-cardiovascular-center
Youtube
Perelman-school-of-medicine
Association-between-beta-blocker

The Pathophysiology of Obstructive Hypertrophic Cardiomyopathy (oHCM)

Andrew Wang, MD, outlines the epidemiology of obstructive hypertrophic cardiomyopathy (oHCM), and Milind Desai, MD, MBA, reviews the etiology of the condition.

Massachusetts
United-states
Boston
Anjali-owens
Milind-desai
Michellem-kittleson
Andrew-wang
Michelle-kittleson
Los-angeles
James-januzzi
Jim-januzzi
Bain-institute-for-clinical-research

5 FDA Decisions to Watch for Through June 2023

From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.

United-states
American
Iapocec-mavacamten
Paul-feuerstadt
Kunzmannk-sotagliflozin
Theodore-leng
Deepak-bhatt
Professor-of-ophthalmology-at-stanford-university
Alexion-pharmaceuticals
American-academy-of-dermatology
Sotagliflozin-lexicon-pharmaceuticals-for-heart-failure
American-college-of-cardiology

Cytokinetics Announces Upcoming Presentations at the 2022

Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLE.

United-states
Oregon
Michigan
Washington
America
Sara-saberi
Niharr-desai
Diane-weiser
Ahmad-masri
School-of-medicine
Division-of-cardiovascular-medicine
Linkedin

vimarsana © 2020. All Rights Reserved.